IBDEI0OE ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30940,2)
 ;;=^5003751^
 ;;^UTILITY(U,$J,358.3,30941,0)
 ;;=G30.8^^91^1337^1
 ;;^UTILITY(U,$J,358.3,30941,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30941,1,3,0)
 ;;=3^Alzheimer's Disease NEC
 ;;^UTILITY(U,$J,358.3,30941,1,4,0)
 ;;=4^G30.8
 ;;^UTILITY(U,$J,358.3,30941,2)
 ;;=^5003807
 ;;^UTILITY(U,$J,358.3,30942,0)
 ;;=A81.89^^91^1337^5
 ;;^UTILITY(U,$J,358.3,30942,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30942,1,3,0)
 ;;=3^Atypical Virus Infections of CNS NEC
 ;;^UTILITY(U,$J,358.3,30942,1,4,0)
 ;;=4^A81.89
 ;;^UTILITY(U,$J,358.3,30942,2)
 ;;=^5000413
 ;;^UTILITY(U,$J,358.3,30943,0)
 ;;=G20.^^91^1337^69
 ;;^UTILITY(U,$J,358.3,30943,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30943,1,3,0)
 ;;=3^Parkinson's Disease
 ;;^UTILITY(U,$J,358.3,30943,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,30943,2)
 ;;=^5003770^
 ;;^UTILITY(U,$J,358.3,30944,0)
 ;;=G23.1^^91^1337^73
 ;;^UTILITY(U,$J,358.3,30944,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30944,1,3,0)
 ;;=3^Progressive Supranuclear Ophthalmoplegia Palsy
 ;;^UTILITY(U,$J,358.3,30944,1,4,0)
 ;;=4^G23.1
 ;;^UTILITY(U,$J,358.3,30944,2)
 ;;=^5003780
 ;;^UTILITY(U,$J,358.3,30945,0)
 ;;=F03.91^^91^1337^17
 ;;^UTILITY(U,$J,358.3,30945,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30945,1,3,0)
 ;;=3^Dementia w/ Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,30945,1,4,0)
 ;;=4^F03.91
 ;;^UTILITY(U,$J,358.3,30945,2)
 ;;=^5133350
 ;;^UTILITY(U,$J,358.3,30946,0)
 ;;=F03.90^^91^1337^19
 ;;^UTILITY(U,$J,358.3,30946,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30946,1,3,0)
 ;;=3^Dementia w/o Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,30946,1,4,0)
 ;;=4^F03.90
 ;;^UTILITY(U,$J,358.3,30946,2)
 ;;=^5003050
 ;;^UTILITY(U,$J,358.3,30947,0)
 ;;=F02.81^^91^1337^40
 ;;^UTILITY(U,$J,358.3,30947,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30947,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob ALZHEIMER'S DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,30947,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,30947,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,30948,0)
 ;;=F02.80^^91^1337^41
 ;;^UTILITY(U,$J,358.3,30948,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30948,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob ALZHEIMER'S DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,30948,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,30948,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,30949,0)
 ;;=G31.84^^91^1337^56
 ;;^UTILITY(U,$J,358.3,30949,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30949,1,3,0)
 ;;=3^Mild Neurocog D/O d/t ALZHEIMER'S DISEASE
 ;;^UTILITY(U,$J,358.3,30949,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,30949,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,30950,0)
 ;;=F02.81^^91^1337^24
 ;;^UTILITY(U,$J,358.3,30950,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30950,1,3,0)
 ;;=3^Major Neurocog D/O d/t ANOTHER MED COND w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,30950,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,30950,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,30951,0)
 ;;=F02.80^^91^1337^25
 ;;^UTILITY(U,$J,358.3,30951,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30951,1,3,0)
 ;;=3^Major Neurocog D/O d/t ANOTHER MED COND w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,30951,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,30951,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,30952,0)
 ;;=G31.84^^91^1337^57
 ;;^UTILITY(U,$J,358.3,30952,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30952,1,3,0)
 ;;=3^Mild Neurocog D/O d/t ANOTHER MEDICAL CONDITION
 ;;^UTILITY(U,$J,358.3,30952,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,30952,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,30953,0)
 ;;=A81.01^^91^1337^9
 ;;^UTILITY(U,$J,358.3,30953,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30953,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Variant
 ;;^UTILITY(U,$J,358.3,30953,1,4,0)
 ;;=4^A81.01
 ;;^UTILITY(U,$J,358.3,30953,2)
 ;;=^336701
 ;;^UTILITY(U,$J,358.3,30954,0)
 ;;=F05.^^91^1337^13
 ;;^UTILITY(U,$J,358.3,30954,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30954,1,3,0)
 ;;=3^Delirium d/t Another Medical Condition
 ;;^UTILITY(U,$J,358.3,30954,1,4,0)
 ;;=4^F05.
 ;;^UTILITY(U,$J,358.3,30954,2)
 ;;=^5003052
 ;;^UTILITY(U,$J,358.3,30955,0)
 ;;=F05.^^91^1337^14
 ;;^UTILITY(U,$J,358.3,30955,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30955,1,3,0)
 ;;=3^Delirium d/t Multiple Etiologies
 ;;^UTILITY(U,$J,358.3,30955,1,4,0)
 ;;=4^F05.
 ;;^UTILITY(U,$J,358.3,30955,2)
 ;;=^5003052
 ;;^UTILITY(U,$J,358.3,30956,0)
 ;;=R41.0^^91^1337^15
 ;;^UTILITY(U,$J,358.3,30956,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30956,1,3,0)
 ;;=3^Delirium,Other Specified
 ;;^UTILITY(U,$J,358.3,30956,1,4,0)
 ;;=4^R41.0
 ;;^UTILITY(U,$J,358.3,30956,2)
 ;;=^5019436
 ;;^UTILITY(U,$J,358.3,30957,0)
 ;;=R41.0^^91^1337^16
 ;;^UTILITY(U,$J,358.3,30957,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30957,1,3,0)
 ;;=3^Delirium,Unspec
 ;;^UTILITY(U,$J,358.3,30957,1,4,0)
 ;;=4^R41.0
 ;;^UTILITY(U,$J,358.3,30957,2)
 ;;=^5019436
 ;;^UTILITY(U,$J,358.3,30958,0)
 ;;=G31.09^^91^1337^20
 ;;^UTILITY(U,$J,358.3,30958,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30958,1,3,0)
 ;;=3^Frontotemporal Disease
 ;;^UTILITY(U,$J,358.3,30958,1,4,0)
 ;;=4^G31.09
 ;;^UTILITY(U,$J,358.3,30958,2)
 ;;=^329916
 ;;^UTILITY(U,$J,358.3,30959,0)
 ;;=F02.81^^91^1337^36
 ;;^UTILITY(U,$J,358.3,30959,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30959,1,3,0)
 ;;=3^Major Neurocog D/O d/t Poss FRONTOTEMP LOBAR DEGEN w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,30959,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,30959,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,30960,0)
 ;;=F02.80^^91^1337^37
 ;;^UTILITY(U,$J,358.3,30960,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30960,1,3,0)
 ;;=3^Major Neurocog D/O d/t Poss FRONTOTEMP LOBAR DEGEN w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,30960,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,30960,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,30961,0)
 ;;=F02.81^^91^1337^42
 ;;^UTILITY(U,$J,358.3,30961,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30961,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob FRONTOTEMP LOBAR DEGEN w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,30961,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,30961,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,30962,0)
 ;;=F02.80^^91^1337^43
 ;;^UTILITY(U,$J,358.3,30962,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30962,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob FRONTOTEMP LOBAR DEGEN w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,30962,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,30962,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,30963,0)
 ;;=G31.84^^91^1337^58
 ;;^UTILITY(U,$J,358.3,30963,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30963,1,3,0)
 ;;=3^Mild Neurocog D/O d/t FRONTOTEMP LOBAR DEGEN
 ;;^UTILITY(U,$J,358.3,30963,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,30963,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,30964,0)
 ;;=F02.81^^91^1337^26
 ;;^UTILITY(U,$J,358.3,30964,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30964,1,3,0)
 ;;=3^Major Neurocog D/O d/t HIV INFECTION w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,30964,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,30964,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,30965,0)
 ;;=F02.80^^91^1337^27
 ;;^UTILITY(U,$J,358.3,30965,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30965,1,3,0)
 ;;=3^Major Neurocog D/O d/t HIV INFECTION w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,30965,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,30965,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,30966,0)
 ;;=G31.84^^91^1337^59
 ;;^UTILITY(U,$J,358.3,30966,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30966,1,3,0)
 ;;=3^Mild Neurocog D/O d/t HIV INFECTION
 ;;^UTILITY(U,$J,358.3,30966,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,30966,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,30967,0)
 ;;=F02.81^^91^1337^28
 ;;^UTILITY(U,$J,358.3,30967,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30967,1,3,0)
 ;;=3^Major Neurocog D/O d/t HUNTINGTON'S DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,30967,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,30967,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,30968,0)
 ;;=F02.80^^91^1337^29
 ;;^UTILITY(U,$J,358.3,30968,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30968,1,3,0)
 ;;=3^Major Neurocog D/O d/t HUNTINGTON'S DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,30968,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,30968,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,30969,0)
 ;;=G31.84^^91^1337^60
 ;;^UTILITY(U,$J,358.3,30969,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30969,1,3,0)
 ;;=3^Mild Neurocog D/O d/t HUNTINGTON'S DISEASE
 ;;^UTILITY(U,$J,358.3,30969,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,30969,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,30970,0)
 ;;=G31.83^^91^1337^23
 ;;^UTILITY(U,$J,358.3,30970,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30970,1,3,0)
 ;;=3^Lewy Body Disease
 ;;^UTILITY(U,$J,358.3,30970,1,4,0)
 ;;=4^G31.83
 ;;^UTILITY(U,$J,358.3,30970,2)
 ;;=^329888
 ;;^UTILITY(U,$J,358.3,30971,0)
 ;;=F02.81^^91^1337^52
 ;;^UTILITY(U,$J,358.3,30971,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30971,1,3,0)
 ;;=3^Major Neurocog D/O w/ Poss LEWY BODIES w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,30971,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,30971,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,30972,0)
 ;;=F02.80^^91^1337^53
 ;;^UTILITY(U,$J,358.3,30972,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30972,1,3,0)
 ;;=3^Major Neurocog D/O w/ Poss LEWY BODIES w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,30972,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,30972,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,30973,0)
 ;;=F02.81^^91^1337^54
 ;;^UTILITY(U,$J,358.3,30973,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30973,1,3,0)
 ;;=3^Major Neurocog D/O w/ Prob LEWY BODIES w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,30973,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,30973,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,30974,0)
 ;;=F02.80^^91^1337^55
 ;;^UTILITY(U,$J,358.3,30974,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30974,1,3,0)
 ;;=3^Major Neurocog D/O w/ Prob LEWY BODIES w/o Behav Disturb
